期刊
INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 13, 期 -, 页码 1179-1213出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S146195
关键词
nanotechnology systems; microbial biofilms; anti-biofilm activity
资金
- Sao Paulo Research Foundation - FAPESP [2014/24626-9, 2016/08559-5]
- Scientific Support and Development Program of School of Pharmaceutical Sciences (UNESP)
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/08559-5, 14/24626-9] Funding Source: FAPESP
Since the dawn of civilization, it has been understood that pathogenic microorganisms cause infectious conditions in humans, which at times, may prove fatal. Among the different virulent properties of microorganisms is their ability to form biofilms, which has been directly related to the development of chronic infections with increased disease severity. A problem in the elimination of such complex structures (biofilms) is resistance to the drugs that are currently used in clinical practice, and therefore, it becomes imperative to search for new compounds that have anti-biofilm activity. In this context, nanotechnology provides secure platforms for targeted delivery of drugs to treat numerous microbial infections that are caused by biofilms. Among the many applications of such nanotechnology-based drug delivery systems is their ability to enhance the bioactive potential of therapeutic agents. The present study reports the use of important nanoparticles, such as liposomes, microemulsions, cyclodextrins, solid lipid nanoparticles, polymeric nanoparticles, and metallic nanoparticles, in controlling microbial biofilms by targeted drug delivery. Such utilization of these nanosystems has led to a better understanding of their applications and their role in combating biofilms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据